SPAG5 and breast carcinoma: In breast cancer, high Astrin expression is associated with a higher sensitivity of combination cytotoxic chemotherapy; however, Astrin knockdown also increased sensitivity to the poly ADP-ribose polymerase inhibitor Olaparib.